The number of people with susceptibility test result for rifampicin in Belgium
Belgium: The number of people with susceptibility test result for rifampicin was 377 in 2021. ▼ Falling
Latest (2021)
377
Change on year
up 17.8%
World rank
86th
of 155 countries
All-time high
437
in 2019
All-time low
320
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Belgium, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Belgium recorded 377 for the number of people with susceptibility test result for rifampicin in 2021.
The figure is up 17.8% on the previous year and down 11.5% over five years.
That places Belgium 86th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Belgium, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 426 | — |
| 2018 | 427 | +0.2% |
| 2019 | 437 | +2.3% |
| 2020 | 320 | -26.8% |
| 2021 | 377 | +17.8% |
Belgium compared with similar countries
- Belgium's 377 is above the median for high income countries, which is 142, 2.7× the median. (61 countries reporting)
- Belgium's 377 is above the median for Europe & Central Asia, which is 229.5, 1.6× the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 430 | 426 | 437 | 3 |
| 2020s | 348.5 | 320 | 377 | 2 |
Countries ranked near Belgium
- 83 Bhutan 419 compare
- 84 Qatar 411 compare
- 85 Kuwait 401 compare
- 87 El Salvador 316 compare
- 88 Netherlands 270 compare
- 89 Bosnia and Herzegovina 255 compare
More health data for Belgium
- Un projection of annual infant deaths, annual growth rate -3.28 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2923 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,160 deaths per 1,000 people (2090)
- Number of infants who die before age 1 59 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.11 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0229 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.96 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Belgium?
- The number of people with susceptibility test result for rifampicin in Belgium was 377 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Belgium?
- The highest recorded value was 437 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Belgium?
- The lowest recorded value was 320 in 2020.
- How does Belgium rank for the number of people with susceptibility test result for rifampicin?
- Belgium ranks 86th out of 155 countries with data for 2021.
- Where does this Belgium data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).